myTAKE: A new dawn for CME?

Share this content:

What's the future of continuing medical education (CME)? CME professionals have gathered in San Francisco for the next couple days to bat around that question and its various implications at the 42nd Annual Conference of the Alliance for Continuing Education in the Health Professions.

Working under the theme “Shaping Our Profession — Demonstrating Our Value,” the conference, which opens today, takes place at the doorstep of great change in healthcare and healthcare education. With a new administration in Washington promising less regulation for both healthcare and industry, new value-based reimbursement for clinicians (can the conference's value theme be a coincidence?), and emerging technologies such as virtual reality and simulation promising great change, how this group responds will go a long way in determining what CME will look like tomorrow.

Among the issues bound to arise:

  • What is this MIPS thing and why does it matter for CME?
  • What new educational techniques can we expect in CME offerings?
  • What role will technology play in CME?
  • Will this be the year there is agreement on how to handle MOC requirements?
  • Must all CME have a "C"--that is, does uncertified medical education have a role in the brave new value-based world?
  • How does social media fit in?

Conference sessions will cover most of these questions and many others, and we'll give you a front-row seat, but without the airfare and hotel bill. Watch this space for daily updates on what you need to know from the conference.

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Fish Intake Appears to Reduce RA Symptoms

Higher Fish Intake Appears to Reduce RA Symptoms

Researchers suggest most varieties of fish may play a role in controlling symptoms

Longer Survival for Midostaurin  Chemotherapy in AML With FLT3

Longer Survival for Midostaurin + Chemotherapy in AML ...

Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation

HIV Testing Inadequate in Young Men Who Have Sex With Men

HIV Testing Inadequate in Young Men Who Have ...

Only 28 percent of young MSM have HIV testing, though they account for 83 percent of new diagnoses

is free, fast, and customized just for you!

Already a member?

Sign In Now »